title: Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.
authors.affiliation: Food and Drug Administration, Rockville, MD 20857.
authors.forename: R B
authors.initials: RB
authors.lastname: Merkatz
authors.forename: R
authors.initials: R
authors.lastname: Temple
authors.forename: S
authors.initials: S
authors.lastname: Subel
authors.forename: K
authors.initials: K
authors.lastname: Feiden
authors.forename: D A
authors.initials: DA
authors.lastname: Kessler
mesh_terms: D002986:Clinical Trials as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D008297:Male; D016134:Organizational Policy; D011247:Pregnancy / Q000187:drug effects; D012727:Sex Characteristics; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*; D014930:Women